More heart failure patients will be taking an aldosterone antagonist

November 2003

More heart failure patients will be taking an aldosterone antagonist...spironolactone or the new Inspra (eplerenone).

Spironolactone improves survival in patients with severe heart failure and reduced left ventricular function.

Inspra improves survival in patients who've had a heart attack and who also have decreased heart function.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote